[go: up one dir, main page]

CN102875551A - Chloro alkaloid compound and preparation and application thereof - Google Patents

Chloro alkaloid compound and preparation and application thereof Download PDF

Info

Publication number
CN102875551A
CN102875551A CN 201210272060 CN201210272060A CN102875551A CN 102875551 A CN102875551 A CN 102875551A CN 201210272060 CN201210272060 CN 201210272060 CN 201210272060 A CN201210272060 A CN 201210272060A CN 102875551 A CN102875551 A CN 102875551A
Authority
CN
China
Prior art keywords
chloro
alkaloid compound
preparation
ethyl acetate
chloroform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN 201210272060
Other languages
Chinese (zh)
Inventor
季乃云
苗凤萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yantai Institute of Coastal Zone Research of CAS
Original Assignee
Yantai Institute of Coastal Zone Research of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yantai Institute of Coastal Zone Research of CAS filed Critical Yantai Institute of Coastal Zone Research of CAS
Priority to CN 201210272060 priority Critical patent/CN102875551A/en
Publication of CN102875551A publication Critical patent/CN102875551A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

本发明涉及抑藻剂、杀虫剂和抑菌剂领域,具体地说是一种海藻内生真菌来源的氯代生物碱类化合物及其制备和应用。具体结构式如(I)所示,其制备方法为将杂色曲霉(Aspergillus versicolor)DL-29接种于真菌液体培养基中发酵培养,发酵产物纯化后,即为式(I)所示的氯代生物碱类化合物。本发明获得的氯代生物碱类化合物,经抑藻活性实验得出化合物半数抑制浓度为6.3微克/毫升,同时该化合物还具有杀虫和抑菌活性。 The invention relates to the fields of algicides, insecticides and bacteriostats, in particular to a chlorinated alkaloid compound derived from seaweed endophytic fungi and its preparation and application. The specific structural formula is shown in (I), and its preparation method is to inoculate Aspergillus versicolor (Aspergillus versicolor) DL-29 in a fungal liquid medium for fermentation and culture. After the fermentation product is purified, it is the chlorinated compound shown in formula (I). Alkaloid compounds. The chlorinated alkaloid compound obtained by the present invention has a half inhibitory concentration of 6.3 micrograms/milliliter obtained through an algae-inhibiting activity test, and the compound also has insecticidal and bacteriostatic activities.

Description

一种氯代生物碱类化合物及其制备和应用A kind of chlorinated alkaloid compound and its preparation and application

技术领域 technical field

本发明涉及抑藻剂、杀虫剂和抑菌剂领域,具体地说是一种海藻内生真菌来源的氯代生物碱类化合物及其制备和应用。  The invention relates to the fields of algicides, insecticides and bacteriostats, in particular to a chlorinated alkaloid compound derived from seaweed endophytic fungi and its preparation and application. the

背景技术 Background technique

随着国民经济的快速发展,海洋污染问题日益加剧,特别是富营养化程度的提高,导致有害赤潮频繁发生,对海洋环境、海洋生物和沿海养殖业带来了严重的危害,因此,发展有害赤潮微藻抑制剂具有重要的应用价值。  With the rapid development of the national economy, the problem of marine pollution has become increasingly serious, especially the increase in the degree of eutrophication, resulting in frequent occurrence of harmful red tides, which have brought serious harm to the marine environment, marine life and coastal aquaculture. Therefore, the development of harmful Red tide microalgae inhibitors have important application value. the

二十世纪以来,化学合成农药的大量使用对水体和土壤带来了严重的污染,超过2/3的农药直接渗透到环境中,残留非常严重,对生物和人类健康都造成直接和潜在的危害。与化学合成农药相比,生物源农药具有环境兼容性好,不易产生抗性等优点,其开发应用对人类健康、环境保护和农业的可持续发展都具有极其重要的意义。  Since the 20th century, the extensive use of chemically synthesized pesticides has brought serious pollution to water bodies and soils. More than 2/3 of the pesticides have directly penetrated into the environment, and the residues are very serious, causing direct and potential harm to organisms and human health. . Compared with chemically synthesized pesticides, biological pesticides have the advantages of good environmental compatibility and less resistance. Their development and application are of great significance to human health, environmental protection and sustainable development of agriculture. the

细菌性疾病仍然是人类和其它生物重要的疾病类型。由于致病性细菌的变异速度比较快,并不断产生抗药性等,开发新型细菌抑制剂依然十分迫切。  Bacterial diseases remain an important type of disease in humans and other organisms. Due to the rapid mutation rate of pathogenic bacteria and the continuous emergence of drug resistance, it is still very urgent to develop new bacterial inhibitors. the

发明内容 Contents of the invention

本发明的目的是提供一种氯代生物碱类化合物及其制备和应用。  The object of the present invention is to provide a chlorinated alkaloid compound and its preparation and application. the

为实现上述目的,本发明采用的技术方案为:  To achieve the above object, the technical solution adopted in the present invention is:

一种氯代生物碱类化合物,氯代生物碱类化合物如式(I)所示  A chlorinated alkaloid compound, the chlorinated alkaloid compound is shown in formula (I)

氯代生物碱类化合物的制备方法,将杂色曲霉(Aspergillus versicolor)DL-29接种于真菌液体培养基中发酵培养,发酵产物纯化后,即为式(I)所示的氯代生物碱类化合物,所述杂色曲霉(Aspergillus versicolor)DL-29,其于2011年11月25日保存于中国典型培养物保藏中心CCTCC,保藏编号为CCTCC M 2011421  The preparation method of the chlorinated alkaloid compound is to inoculate Aspergillus versicolor DL-29 in the fungal liquid medium for fermentation and culture, after the fermentation product is purified, it is the chlorinated alkaloid represented by the formula (I) Compound, said Aspergillus versicolor (Aspergillus versicolor) DL-29, which was preserved in China Center for Type Culture Collection CCTCC on November 25, 2011, and the preservation number is CCTCC M 2011421

Figure BDA00001959679300021
Figure BDA00001959679300021

具体制备步骤:  Specific preparation steps:

1)将杂色曲霉(Aspergillus versicolor)DL-29接种于真菌液体培养基中静止发酵10-60天,过滤,发酵液经乙酸乙酯萃取浓缩,收集的菌丝体用有机溶剂提取,而后再经乙酸乙酯萃取浓缩,发酵液所得浓缩物和菌丝体所得浓缩物合并,即为粗提物;  1) Inoculate Aspergillus versicolor (Aspergillus versicolor) DL-29 in the fungal liquid medium and ferment for 10-60 days, filter, extract and concentrate the fermentation broth with ethyl acetate, extract the collected mycelium with an organic solvent, and then After extraction and concentration with ethyl acetate, the concentrate obtained from the fermentation broth and the concentrate obtained from the mycelia are combined to form the crude extract;

所述杂色曲霉(Aspergillus versicolor)DL-29,其于2011年11月25日保存于中国典型培养物保藏中心CCTCC,保藏编号为CCTCC M 2011421,保藏单位地址:武汉大学;  The Aspergillus versicolor (Aspergillus versicolor) DL-29 was preserved in the China Center for Type Culture Collection CCTCC on November 25, 2011, the preservation number is CCTCC M 2011421, and the address of the depository unit is: Wuhan University;

2)取步骤1)中的粗提物进行硅胶柱层析,用有机溶剂进行梯度洗脱,收集洗脱液,洗脱液经薄层层析检测;  2) The crude extract in step 1) is subjected to silica gel column chromatography, gradient elution is performed with an organic solvent, the eluate is collected, and the eluate is detected by thin layer chromatography;

3)收集步骤2)中以洗脱液体积比3-0:1梯度的洗脱组分,将收集的洗脱组分进行硅胶柱层析、凝胶柱层析和薄层层析分离纯化,纯化收集Rf值为0.6-0.7组分,即得如式(I)所示的氯代生物碱类化合物。  3) Collect the eluted components in step 2) with a gradient of eluent volume ratio of 3-0:1, and perform separation and purification of the collected eluted components by silica gel column chromatography, gel column chromatography and thin layer chromatography , purify and collect components with an Rf value of 0.6-0.7 to obtain a chlorinated alkaloid compound as shown in formula (I). the

步骤1)中菌丝体用有机溶剂提取,有机溶剂为庚烷、己烷、戊烷、氯仿、二氯甲烷、乙酸乙酯、丙酮、异丙醇、丙醇、乙醇或甲醇中一种或几种,所述几种物质组合时以任意比例混合。  The mycelium in step 1) is extracted with an organic solvent, and the organic solvent is one of heptane, hexane, pentane, chloroform, dichloromethane, ethyl acetate, acetone, isopropanol, propanol, ethanol or methanol Several kinds, when the several kinds of substances are combined, they are mixed in any proportion. the

步骤2)中的有机溶剂为石油醚-乙酸乙酯、氯仿-乙酸乙酯、石油醚-丙酮、氯仿-丙酮或氯仿-甲醇。  The organic solvent in step 2) is petroleum ether-ethyl acetate, chloroform-ethyl acetate, petroleum ether-acetone, chloroform-acetone or chloroform-methanol. the

步骤3)所述硅胶柱层析洗脱液为体积比3-1:1的石油醚-乙酸乙酯;凝胶柱层析洗脱液为体积比0-2:1的氯仿-甲醇或氯仿-乙醇;薄层层析展开剂为体积比为2-1:1的氯仿-乙酸乙酯或石油醚-乙酸乙酯。  Step 3) The silica gel column chromatography eluent is petroleum ether-ethyl acetate with a volume ratio of 3-1:1; the gel column chromatography eluent is chloroform-methanol or chloroform with a volume ratio of 0-2:1 -Ethanol; The thin-layer chromatography developer is chloroform-ethyl acetate or petroleum ether-ethyl acetate with a volume ratio of 2-1:1. the

步骤3)所述硅胶柱和凝胶柱层析时收集淡黄色斑点的组分。  Step 3) The components with light yellow spots were collected during the silica gel column and gel column chromatography. the

氯代生物碱类化合物的应用,所述氯代生物碱类化合物用于制备抑藻剂、杀虫剂或抑菌剂。所述氯代生物碱类化合物用于制备抑制赤潮异湾藻的制剂。所述氯代生物碱类化合物用于制备卤虫的杀虫制剂。所述氯代生物碱类化合物用于制备奇异变形杆菌、阴沟肠杆菌或蜡状芽孢杆菌的杀菌制剂。  The application of the chlorinated alkaloid compound, the chlorinated alkaloid compound is used for preparing an algastatic agent, an insecticide or a bacteriostatic agent. The chlorinated alkaloid compound is used for preparing a preparation for inhibiting the algae of Akashiwa. The chlorinated alkaloid compound is used for preparing an insecticidal preparation for Artemia. The chlorinated alkaloid compound is used for preparing the bactericidal preparation of Proteus mirabilis, Enterobacter cloacae or Bacillus cereus. the

本发明具有以下优点:本发明通过分离于海洋绿藻刺松藻的杂色曲霉(Aspergillus versicolor)DL-29发酵经提取、分离获得的氯代生物碱类化合物,经抑藻活性实验得出化合物半数抑制浓度为6.3微克/毫升,同时该化合物还具有杀虫和抑菌活性。  The present invention has the following advantages: the present invention extracts and separates the chlorinated alkaloid compounds obtained through the fermentation of Aspergillus versicolor (Aspergillus versicolor) DL-29, which is isolated from the marine green algae Aspergillus versicolor (Aspergillus versicolor) DL-29. The half-inhibitory concentration is 6.3 μg/ml, and the compound also has insecticidal and bacteriostatic activities. the

具体实施方式 Detailed ways

下面结合实施实例对本发明做进一步阐述。  The present invention will be further elaborated below in conjunction with implementation examples. the

实施例1  Example 1

海藻内生真菌来源的氯代生物碱类化合物如式(I)所示。  The chlorinated alkaloid compound derived from endophytic fungi of seaweed is represented by formula (I). the

Figure BDA00001959679300031
Figure BDA00001959679300031

实施例2  Example 2

如式(I)所示的生物碱类化合物的制备方法:  The preparation method of the alkaloid compound shown in formula (I):

取平板上生长良好的真菌杂色曲霉(Aspergillus versicolor)DL-29菌种,切成小块接种于PDB液体培养基中,每1L三角瓶中放300mL培养基,共50瓶,室温静止发酵30天,加入发酵液二分之一体积的乙酸乙酯杀灭真菌,过滤,分别收集菌丝体和发酵液。所述PDB液体培养基组成为每升含土豆汁200毫升,葡萄糖20克,蛋白胨5克,酵母膏3克,陈海水500毫升,蒸馏水300毫升。真菌杂色曲霉(Aspergillus versicolor)DL-29菌种2011年11月25日保存于中国典型培养物保藏中心CCTCC,保藏编号为CCTCC M 2011421,分类命名:Aspergillus versicolor,株号为DL-29;  Take the fungus Aspergillus versicolor (Aspergillus versicolor) DL-29 strain that grew well on the plate, cut it into small pieces and inoculate it in PDB liquid medium, put 300mL medium in each 1L triangular flask, 50 bottles in total, and ferment statically at room temperature for 30 One-half volume of ethyl acetate was added to the fermented liquid to kill fungi, filtered, and the mycelia and fermented liquid were collected respectively. The PDB liquid medium consists of 200 milliliters of potato juice per liter, 20 grams of glucose, 5 grams of peptone, 3 grams of yeast extract, 500 milliliters of aged sea water, and 300 milliliters of distilled water. The fungus Aspergillus versicolor (Aspergillus versicolor) DL-29 strain was preserved in China Center for Type Culture Collection CCTCC on November 25, 2011, the preservation number is CCTCC M 2011421, the classification name is Aspergillus versicolor, and the strain number is DL-29;

收集发酵液约15L,用乙酸乙酯萃取三次,减压浓缩;菌丝体粉碎后用体积比1:1的氯仿-甲醇提取三次,再用乙酸乙酯萃取,减压浓缩;浓缩物经薄层层析检测(石油醚-乙酸乙酯20-0:1,硫酸-茴香醛显色)其结果相似,合并发酵液和菌丝体两部分的浓缩物为粗提物29.4g。  Collect about 15 L of fermentation broth, extract three times with ethyl acetate, and concentrate under reduced pressure; after crushing the mycelia, extract three times with chloroform-methanol with a volume ratio of 1:1, then extract with ethyl acetate, and concentrate under reduced pressure; The results of layer chromatography detection (petroleum ether-ethyl acetate 20-0:1, sulfuric acid-anisaldehyde color development) were similar, and the concentrate of the two parts of the combined fermentation broth and mycelium was 29.4g of crude extract. the

将粗提物进行100-200目的硅胶柱层析,用石油醚-乙酸乙酯以体积比100:0,50:1,20:1,10:1,5:1,2:1到0:100的梯度进行洗脱,分别收集洗脱液,再用薄层层析(TLC)检测(石油醚-乙酸乙酯20-0:1,茴香醛-硫酸作为显色剂),根据Rf值来判断、合并相同或类似部分,获得14个组分(1-14)。  The crude extract was subjected to 100-200 mesh silica gel column chromatography, and petroleum ether-ethyl acetate was used at a volume ratio of 100:0, 50:1, 20:1, 10:1, 5:1, 2:1 to 0: The gradient of 100 was used for elution, and the eluents were collected separately, and then detected by thin layer chromatography (TLC) (petroleum ether-ethyl acetate 20-0:1, anisaldehyde-sulfuric acid as the color reagent), according to the Rf value Judging and merging the same or similar parts to obtain 14 components (1-14). the

将组分14即以石油醚-乙酸乙酯0:100梯度洗脱下的组分再进行硅胶柱、凝胶柱和薄层层析分离。硅胶柱层析洗脱液为体积比2:1的石油醚-乙酸乙酯,TLC检测(氯仿-乙酸乙酯1:1,硫酸-茴香醛显色),收集淡黄色斑点的组分;凝胶柱层析时洗脱液用体积比1:1的氯仿-甲醇,TLC检测(氯仿-乙酸乙酯1:1,硫酸-茴香醛显色),收集淡黄色斑点的组分;薄层层析用体积比1:1的氯仿-乙酸乙酯为展开剂,收集Rf值为0.6-0.7的组分,得式(I)所示化合物(8.6毫克),经TLC检测(氯仿-乙酸乙酯1:1,硫酸-茴香醛显色),呈单个、均匀淡黄色斑点,确定为纯化合物。经波谱分析,其结构鉴定为一种新的生物碱,结构式如(I)所示。  Fraction 14, which was eluted with petroleum ether-ethyl acetate 0:100 gradient, was separated by silica gel column, gel column and thin-layer chromatography. The eluent of silica gel column chromatography is petroleum ether-ethyl acetate at a volume ratio of 2:1, detected by TLC (chloroform-ethyl acetate 1:1, sulfuric acid-anisaldehyde for color development), and the components of light yellow spots are collected; During gel column chromatography, use chloroform-methanol with a volume ratio of 1:1 as the eluent, and detect with TLC (chloroform-ethyl acetate 1:1, sulfuric acid-anisaldehyde for color development), and collect the components with light yellow spots; thin layer Chloroform-ethyl acetate with a volume ratio of 1:1 was used as a developing solvent for analysis, and components with an Rf value of 0.6-0.7 were collected to obtain the compound (8.6 mg) shown in formula (I), which was detected by TLC (chloroform-ethyl acetate 1:1, sulfuric acid-anisaldehyde color development), a single, uniform light yellow spot, identified as a pure compound. After spectral analysis, its structure was identified as a new alkaloid, and its structural formula is shown in (I). the

Figure BDA00001959679300041
Figure BDA00001959679300041

该化合物具有以下理化和波谱特性:  The compound has the following physicochemical and spectroscopic properties:

无色胶状,比旋光度[α]23 D+17.8°(c0.18,MeOH);核磁共振氢谱(1H-NMR,CDCl3,500MHz)δH7.45,d(7.4),7.29,dd(7.2,7.4),7.44,dd(7.2,8.0),7.58,d(8.0),1.99,dd(13.6,1.6),2.48,d(13.6),6.29,s,3.93,s,2.54,ddd(8.8,8.8,8.8),3.00ddd(8.8,8.8,2.8),1.88,m,1.93,m,1.54,m,2.07,m,2.48,m,1.50,m,2.00,m,1.82,dd(12.5,3.4),1.26,s,1.49,s;核磁共振碳谱(13C-NMR,CDCl3,125MHz)δC184.4,qC,86.2,qC,135.2,qC,123.0,CH,126.9,CH,131.1,CH,121.3,CH,152.7,qC,38.0,CH2,54.6,qC,151.6,qC,113.0,qC,61.4,CH,50.6,CH2,21.4,CH2,30.1,CH2,58.4,CH,27.4,CH2,49.0,CH,39.3,qC,22.0,CH3,27.2,CH3;高分辨质谱(HREIMS)[M]+m/z427.1660,计算值427.1663。  Colorless gel, specific rotation [α] 23 D +17.8°(c0.18, MeOH); H NMR spectrum ( 1 H-NMR, CDCl 3 , 500MHz) δ H 7.45,d(7.4),7.29, dd(7.2,7.4),7.44,dd(7.2,8.0),7.58,d(8.0),1.99,dd(13.6,1.6),2.48,d(13.6),6.29,s,3.93,s,2.54,ddd (8.8,8.8,8.8),3.00ddd(8.8,8.8,2.8),1.88,m,1.93,m,1.54,m,2.07,m,2.48,m,1.50,m,2.00,m,1.82,dd( 12.5,3.4), 1.26, s, 1.49, s; C NMR spectrum ( 13 C-NMR, CDCl 3 , 125MHz) δ C 184.4, qC, 86.2, qC, 135.2, qC, 123.0, CH, 126.9, CH, 131.1, CH, 121.3, CH, 152.7, qC, 38.0, CH2 , 54.6, qC, 151.6, qC, 113.0 , qC, 61.4, CH, 50.6, CH2, 21.4, CH2 , 30.1, CH2 , 58.4, CH, 27.4, CH2 , 49.0, CH, 39.3, qC, 22.0, CH3 , 27.2, CH3 ; High resolution mass spectrum (HREIMS) [M] + m/z 427.1660, calculated 427.1663.

实施例3  Example 3

与实施例2不同之处在于  The difference from Example 2 is that

取平板上生长良好的真菌杂色曲霉(Aspergillus versicolor)DL-29菌种接种于JY液体培养基中,每1L三角瓶中放300mL培养基,共50瓶,室温静止发酵20天,加入发酵液二分之一体积乙酸乙酯杀灭真菌,过滤,分别收集菌丝体和发酵液。所述JY液体培养基组成为每升含菊芋块茎汁500毫升,葡萄糖10克,硝酸钠2.0克,陈海水500毫升。  Take the fungus Aspergillus versicolor (Aspergillus versicolor) DL-29 strain that grew well on the plate and inoculate it in JY liquid medium, put 300mL medium in each 1L Erlenmeyer flask, 50 bottles in total, ferment statically at room temperature for 20 days, add fermentation broth One-half volume of ethyl acetate kills fungi, filters, and collects mycelium and fermentation broth respectively. The JY liquid medium consists of 500 milliliters of Jerusalem artichoke tuber juice per liter, 10 grams of glucose, 2.0 grams of sodium nitrate, and 500 milliliters of aged seawater. the

收集发酵液约15L,用乙酸乙酯萃取三次,减压浓缩;菌丝体粉碎后用乙醇提取三次,再用乙酸乙酯萃取,减压浓缩;浓缩物经薄层层析检测(石油醚-乙酸乙酯20-0:1,硫酸-茴香醛显色)其结果相似,合并发酵液和菌丝体两部分的浓缩物为粗提物28.0g。  Collect about 15L of fermentation broth, extract three times with ethyl acetate, and concentrate under reduced pressure; crush the mycelium, extract with ethanol three times, then extract with ethyl acetate, and concentrate under reduced pressure; the concentrate is detected by thin layer chromatography (petroleum ether- Ethyl acetate 20-0:1, sulfuric acid-anisaldehyde color development) the results are similar, the concentrate of the two parts of the combined fermentation broth and mycelia is 28.0g of crude extract. the

将粗提物进行100-200目的硅胶柱层析,用石油醚-丙酮以100:0,50:1,20:1,10:1,5:1,1:1到0:100的梯度进行洗脱,分别收集洗脱液,再用薄层层析(TLC)检测(石油醚-乙酸乙酯20-0:1,硫酸-茴香醛显色),根据Rf值来判断、合并相同或类似部分,获得14个组分(1-14)。  The crude extract was subjected to 100-200 mesh silica gel column chromatography with petroleum ether-acetone at a gradient of 100:0, 50:1, 20:1, 10:1, 5:1, 1:1 to 0:100 Elution, collect the eluents separately, and then detect with thin layer chromatography (TLC) (petroleum ether-ethyl acetate 20-0:1, sulfuric acid-anisaldehyde for color development), judge according to the Rf value, merge the same or similar section, to obtain 14 components (1-14). the

将组分14即以石油醚-丙酮0:100梯度洗脱下的组分再进行硅胶柱、凝胶柱和薄层层析分离。硅胶柱层析洗脱液为体积比2:1的石油醚-乙酸乙酯,TLC检测(氯仿-乙酸乙酯1:1,硫酸-茴香醛显色),收集淡黄色斑点的组分;凝胶柱层析时洗脱液用体积比2:1的氯仿-甲醇,TLC检测(氯仿-乙酸乙酯1:1,硫酸-茴香醛显色),收集淡黄色斑点的组分;薄层层 析用体积比1:1的氯仿-乙酸乙酯为展开剂,收集Rf值为0.6-0.7的组分,得式(I)所示的氯代生物碱类化合物。  Component 14, that is, the component eluted with petroleum ether-acetone 0:100 gradient, was separated by silica gel column, gel column and thin layer chromatography. The eluent of silica gel column chromatography is petroleum ether-ethyl acetate at a volume ratio of 2:1, detected by TLC (chloroform-ethyl acetate 1:1, sulfuric acid-anisaldehyde for color development), and the components of light yellow spots are collected; During gel column chromatography, use chloroform-methanol with a volume ratio of 2:1 as the eluent, and detect with TLC (chloroform-ethyl acetate 1:1, sulfuric acid-anisaldehyde for color development), and collect the components with light yellow spots; thin layer Chloroform-ethyl acetate with a volume ratio of 1:1 is used as a developing solvent for analysis, and components with an Rf value of 0.6-0.7 are collected to obtain a chlorinated alkaloid compound represented by formula (I). the

实施例4  Example 4

赤潮微藻抑制实验:  Red tide microalgae inhibition experiment:

取指数生长期的赤潮异湾藻,用已灭菌的f/2培养基,稀释至一定初始藻细胞密度(5×104个/mL)的实验藻液,备用。将待测试化合物溶于二甲基亚砜(DMSO)制备成母液,备用。Costar96孔板每孔最终试验体积为200微升,由199微升藻液和1微升待测样品溶液构成,实验藻液中DMSO最终浓度为0.5%,每个浓度设定三个平行样,培养期间每日震荡3次,每隔24小时在显微镜下用血球计数板(或浮游生物计数框)进行藻细胞计数观察,测定藻细胞的浓度(个/mL),计算24h的EC50值。  Take I. akashiwo algae in the exponential growth phase, dilute it to a certain initial algae cell density (5×10 4 cells/mL) with sterilized f/2 medium, and set aside for later use. The compound to be tested was dissolved in dimethyl sulfoxide (DMSO) to prepare a mother solution for later use. The final test volume of each well of the Costar96-well plate is 200 microliters, which is composed of 199 microliters of algae liquid and 1 microliter of the sample solution to be tested. The final concentration of DMSO in the experimental algae liquid is 0.5%, and three parallel samples are set for each concentration. Shake 3 times a day during the culture period, observe the algal cell count under the microscope every 24 hours with a hemocytometer (or plankton counting box), measure the concentration of algal cells (unit/mL), and calculate the EC 50 value for 24 hours.

实验结果:上述实施例中的获得的生物碱类化合物对赤潮异湾藻的半数抑制浓度为6.3微克/毫升。  Experimental results: the half-inhibitory concentration of the alkaloid compounds obtained in the above-mentioned examples on I. akashiwo algae was 6.3 micrograms per milliliter. the

实施例5  Example 5

杀虫活性实验:  Insecticidal activity test:

卤虫卵的孵化:取卤虫卵100毫克置于500毫升烧杯中,加入人工海水400毫升,用一小充气泵缓缓充气,室温孵化24小时,除去卵壳及未孵化的卵,卤虫幼虫继续培养24小时,备用。  Hatching of Artemia eggs: Take 100 mg of Artemia eggs and put them in a 500ml beaker, add 400ml of artificial seawater, inflate slowly with a small air pump, and incubate at room temperature for 24 hours, remove egg shells and unhatched eggs, and Artemia The larvae were continued to be cultivated for 24 hours and set aside. the

卤虫生物致死法:依照Solis的改良法,取96孔细胞培养板,每孔加190微升含10个左右卤虫幼虫的人工海水液,制成测试培养板。空白对照组和每个浓度的样品组各设三个平行孔,空白对照组加10微升溶剂二甲基亚砜(DMSO),样品组加10微升式(I)所示的二倍半萜类化合物的溶液(DMSO为溶剂)。室温培养24小时后,在双目解剖镜下检测计数卤虫死亡个体数目。  Artemia biological lethal method: according to the improved method of Solis, take a 96-well cell culture plate, add 190 microliters of artificial seawater containing about 10 Artemia larvae to each hole, and make a test culture plate. Set three parallel wells for the blank control group and the sample group of each concentration, add 10 microliters of solvent dimethyl sulfoxide (DMSO) to the blank control group, and add 10 microliters of the two-and-a-half times shown in formula (I) to the sample group Solution of terpenoids (DMSO as solvent). After incubation at room temperature for 24 hours, the number of dead individuals of Artemia was detected and counted under a binocular dissecting microscope. the

卤虫生物致死活性以校正死亡率表示,计算公式如下:  The biological lethal activity of Artemia is expressed in terms of corrected mortality, and the calculation formula is as follows:

校正死亡率=(对照组存活率-处理组存活率)/对照组存活率×100%  Adjusted mortality rate = (survival rate of control group - survival rate of treatment group) / survival rate of control group × 100%

实验结果:上述实施例中的获得的生物碱类化合物在100微克/毫升时对卤虫的致死率为27.5%。  Experimental results: the lethality of the alkaloid compound obtained in the above example to Artemia was 27.5% at 100 μg/ml. the

实施例6  Example 6

抑菌活性实验:  Antibacterial activity test:

具体为:实验所用的细菌培养基为LB培养基,分别用无菌棉签浸取奇异变形杆菌、阴沟肠杆菌和蜡状芽孢杆菌的菌悬液,均匀涂于培养基上,测试样品溶解于DMSO中,浓度为6.0毫克/毫升,取5微升样品加到直径为5毫米的无菌滤纸片上(每片30微克);并用加有相同体积DMSO的滤纸片做阴性对照,用氯霉素作为抗细菌的阳性对照,各三个平行。加有样品的平板培养基置于28℃静置培养24小时,观察实验结果,出现抑菌圈的测量其抑菌圈直径。  Specifically: the bacterial culture medium used in the experiment is LB culture medium, soak the bacterial suspension of Proteus mirabilis, Enterobacter cloacae and Bacillus cereus with sterile cotton swabs respectively, evenly spread on the culture medium, and the test sample is dissolved in DMSO In the medium, the concentration is 6.0 mg/ml, take 5 microliters of sample and add it to a sterile filter paper piece with a diameter of 5 mm (30 micrograms per piece); and use the filter paper piece with the same volume of DMSO as a negative control, and use chloramphenicol as a negative control. Antibacterial positive control, each in three parallels. Place the plate culture medium with the sample at 28°C for 24 hours, observe the experimental results, and measure the diameter of the inhibition zone if there is an inhibition zone. the

实验结果:上述获得的生物碱类化合物对奇异变形杆菌、阴沟肠杆菌和蜡状芽孢杆菌的抑菌圈直径分别为7.0毫米,6.5毫米和6.0毫米,具有抑制奇异变形杆菌、阴沟肠杆菌或蜡状芽孢杆菌的活性。  Experimental results: the alkaloid compounds obtained above have a bacteriostatic zone diameter of 7.0 mm, 6.5 mm and 6.0 mm respectively to Proteus mirabilis, Enterobacter cloacae and Bacillus cereus, and have the ability to inhibit Proteus mirabilis, Enterobacter cloacae or cereus activity of Bacillus spp. the

Claims (11)

1. chloro alkaloid compound, it is characterized in that: the chloro alkaloid compound as shown in the formula (I)
Figure FDA00001959679200011
2. the preparation method of a chloro alkaloid compound claimed in claim 1, it is characterized in that: aspergillus versicolor (Aspergillus versicolor) DL-29 is inoculated in fermentation culture in the fungi liquid substratum, behind the tunning purifying, be the chloro alkaloid compound shown in the formula (I), described aspergillus versicolor (Aspergillus versicolor) DL-29, it is stored in Chinese Typical Representative culture collection center C CTCC on November 25th, 2011, and deposit number is CCTCC M 2011421
Figure FDA00001959679200012
3. by the preparation method of chloro alkaloid compound claimed in claim 2, it is characterized in that concrete preparation process:
1) aspergillus versicolor (Aspergillus versicolor) DL-29 was inoculated in the fungi liquid substratum static fermentation 10-60 days, filter, fermented liquid is concentrated through ethyl acetate extraction, the mycelium organic solvent extraction of collecting, then concentrated through ethyl acetate extraction again, fermented liquid gained enriched material and mycelium gained enriched material merge, and are crude extract;
Described aspergillus versicolor (Aspergillus versicolor) DL-29, it is stored in Chinese Typical Representative culture collection center C CTCC on November 25th, 2011, and deposit number is CCTCC M 2011421;
2) crude extract of getting in the step 1) carries out silica gel column chromatography, carries out gradient elution with organic solvent, collects elutriant, and elutriant detects through thin-layer chromatography;
3) collect step 2) in the elution fraction of effluent volume than 3-0:1 gradient, the elution fraction of collecting is carried out silica gel column chromatography, gel filtration chromatography and thin-layer chromatography separation and purification, it is the 0.6-0.7 component that purifying is collected the Rf value, namely gets chloro alkaloid compound as shown in the formula (I).
4. press the preparation method of chloro alkaloid compound claimed in claim 3, it is characterized in that: mycelium organic solvent extraction in the step 1), organic solvent are in heptane, hexane, pentane, chloroform, methylene dichloride, ethyl acetate, acetone, Virahol, propyl alcohol, ethanol or the methyl alcohol one or more.
5. by the preparation method of chloro alkaloid compound claimed in claim 3, it is characterized in that: step 2) in organic solvent be petroleum ether-ethyl acetate, chloroform-ethyl acetate, sherwood oil-acetone, chloroform-acetone or chloroform-methanol.
6. by the preparation method of chloro alkaloid compound claimed in claim 3, it is characterized in that: the petroleum ether-ethyl acetate that the described silica gel column chromatography elutriant of step 3) is volume ratio 3-1:1; The gel filtration chromatography elutriant is chloroform-methanol or the chloroform-ethanol of volume ratio 0-2:1; The thin-layer chromatography developping agent is that volume ratio is chloroform-ethyl acetate or the petroleum ether-ethyl acetate of 2-1:1.
7. by the preparation method of chloro alkaloid compound claimed in claim 3, it is characterized in that: the component of collecting faint yellow spot when the described silicagel column of step 3) and gel filtration chromatography.
8. the application of a chloro alkaloid compound claimed in claim 1 is characterized in that: described chloro alkaloid compound is for the preparation of algae-inhibiting agent, sterilant or fungistat.
9. by the application of chloro alkaloid compound claimed in claim 8, it is characterized in that: described chloro alkaloid compound is for the preparation of the preparation that suppresses heterosigma akashiwo.
10. by the application of chloro alkaloid compound claimed in claim 8, it is characterized in that: described chloro alkaloid compound is for the preparation of the pesticide preparation of halogen worm.
11. by the application of chloro alkaloid compound claimed in claim 8, it is characterized in that: described chloro alkaloid compound is for the preparation of the biocide preparation of Proteus mirabilis, enterobacter cloacae or bacillus cereus.
CN 201210272060 2012-07-31 2012-07-31 Chloro alkaloid compound and preparation and application thereof Withdrawn CN102875551A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210272060 CN102875551A (en) 2012-07-31 2012-07-31 Chloro alkaloid compound and preparation and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210272060 CN102875551A (en) 2012-07-31 2012-07-31 Chloro alkaloid compound and preparation and application thereof

Publications (1)

Publication Number Publication Date
CN102875551A true CN102875551A (en) 2013-01-16

Family

ID=47477104

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210272060 Withdrawn CN102875551A (en) 2012-07-31 2012-07-31 Chloro alkaloid compound and preparation and application thereof

Country Status (1)

Country Link
CN (1) CN102875551A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104004662A (en) * 2014-05-22 2014-08-27 黑龙江大学 Aspergillus versicolor strain with antibacterial activity
CN107459527A (en) * 2017-09-22 2017-12-12 中国科学院烟台海岸带研究所 A kind of six ring alkaloid compounds and its preparation and application
CN107629070A (en) * 2017-09-22 2018-01-26 中国科学院烟台海岸带研究所 A kind of carbamate compound and its preparation and application
CN107652305A (en) * 2017-09-22 2018-02-02 中国科学院烟台海岸带研究所 A kind of indoles cyanoalkaloids compound and its preparation and application
CN108484363A (en) * 2018-04-23 2018-09-04 中国科学院烟台海岸带研究所 A kind of three alcohol compound of sequiterpene and its preparation and application
CN118878640A (en) * 2024-10-08 2024-11-01 山东第一医科大学(山东省医学科学院) A fungus-derived cyclic peptide compound and its preparation method and application

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104004662A (en) * 2014-05-22 2014-08-27 黑龙江大学 Aspergillus versicolor strain with antibacterial activity
CN107459527A (en) * 2017-09-22 2017-12-12 中国科学院烟台海岸带研究所 A kind of six ring alkaloid compounds and its preparation and application
CN107629070A (en) * 2017-09-22 2018-01-26 中国科学院烟台海岸带研究所 A kind of carbamate compound and its preparation and application
CN107652305A (en) * 2017-09-22 2018-02-02 中国科学院烟台海岸带研究所 A kind of indoles cyanoalkaloids compound and its preparation and application
CN107459527B (en) * 2017-09-22 2019-07-05 中国科学院烟台海岸带研究所 A kind of hexacyclic alkaloid compound and its preparation and application
CN107629070B (en) * 2017-09-22 2019-07-19 中国科学院烟台海岸带研究所 A kind of carbamate compound and its preparation and application
CN108484363A (en) * 2018-04-23 2018-09-04 中国科学院烟台海岸带研究所 A kind of three alcohol compound of sequiterpene and its preparation and application
CN108484363B (en) * 2018-04-23 2020-12-15 中国科学院烟台海岸带研究所 A kind of sesquiterpene triol compound and its preparation and application
CN118878640A (en) * 2024-10-08 2024-11-01 山东第一医科大学(山东省医学科学院) A fungus-derived cyclic peptide compound and its preparation method and application
CN118878640B (en) * 2024-10-08 2025-01-24 山东第一医科大学(山东省医学科学院) A fungus-derived cyclic peptide compound and its preparation method and application

Similar Documents

Publication Publication Date Title
CN102187870B (en) Application of diterpene alkaloid compound serving as secondary metabolite of seaweed endophytic fungus
CN102643167B (en) Alga endophytic fungus sesquiterpene compound and preparation method and application thereof
CN102875551A (en) Chloro alkaloid compound and preparation and application thereof
CN103937678B (en) One strain ocean shell penicillium sp, its derivative quinolinones compound and preparation thereof and application
Tiwari et al. Antidiabetic activity of endophytic fungi isolated from Ficus religiosa
CN108353906A (en) The application of indole -3-formaldehyde and its derivative in preventing the plant disease caused by plant pathogenic fungi
CN102659912B (en) Oxygen-rich disesquiterpenes compound, and preparation method and application thereof
Enyi et al. Secondary metabolites from endophytic fungi of Moringa oleifera: Antimicrobial and antioxidant properties
CN102786528B (en) Polyoxybiotic alkali compound as well as preparation method and application thereof
CN108753628A (en) One plant of marine fungi pawl aspergillus mutagenic fungi Aspergillus unguis 6-20-6
CN103613490B (en) A kind of norditerpene compound and its preparation and application
CN102701935B (en) Tetranuclear diterpenoids as well as preparation and application thereof
KR20230001353A (en) Composition for controlling plant diseases comprising compound lsolated from Trichoderma longibrachiatum as an active ingredient and method of controlling plant diseases using the same
CN112111409A (en) A strain of Penicillium oxalate and its application
CN102659547B (en) Ophiobolin sesterterpene compound and preparation and application thereof
CN108925565B (en) Application of depside cyclic ether compound
Zhang et al. Bioactivity and constituents of several common seaweeds
CN102675293B (en) Indole diketopiperazines derivatives, preparation method and application thereof
CN108640832B (en) Cadinane sesquiterpenoids, and preparation and application thereof
CN111004106A (en) Polyketone compound with trans-decalin ring and its preparation method and application
Pervez et al. In vitro antimicrobial studies of isolated Myrothecium spp mrp001 against human pathogens
CN113402471B (en) Siderophore compounds derived from endophytic fungi and preparation method and application
CN114369051A (en) Pyrrolidine alcohol compound and preparation method and application thereof
CN108586218B (en) Chloro cyclopentenone compound and preparation and application thereof
CN102190698A (en) Alga endophytic fungi diterpenoid alkaloid compound, preparation method thereof and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C04 Withdrawal of patent application after publication (patent law 2001)
WW01 Invention patent application withdrawn after publication

Application publication date: 20130116